Herbalife Ltd HLF
12.55
0.34
2.78%
as of 25 Sep
- Market cap
- $1.3B
- P/E
- 7.8×
Follow HLF
Growth Flags
show if company had growth for consecutive years,
Insider Buys
alert about insiders buying in the last 12 month
| Jun '26 | Mar '26 | Dec '25 | Sep '25 | Older periods | |
|---|---|---|---|---|---|
P/E ratio |
8.22 | 6.32 | 5.78 | 2.67 |
+8 more quarters Free account |
P/S ratio |
0.26 | 0.30 | 0.26 | 0.18 | |
P/FCF ratio |
4.26 | 4.09 | 5.24 | 4.02 | |
P/Operating CF |
41.77 | 13.43 | 13.48 | 6.28 | |
P/B ratio |
0.00 | 0.00 | 0.00 | 0.00 | |
Price to Tangible BV |
0.00 | 0.00 | 0.00 | 0.00 | |
EV/Sales |
0.58 | 0.60 | 0.59 | 0.52 | |
EV/EBITDA |
4.92 | 4.98 | 4.92 | 4.25 | |
EV/Operating CF |
7.87 | 6.86 | 8.89 | 8.48 | |
EV/FCF |
9.37 | 8.21 | 11.72 | 11.91 | |
Quick Ratio |
0.50 | 0.55 | 0.44 | 0.40 | |
Current Ratio |
1.20 | 1.23 | 1.13 | 1.11 | |
Net Debt/EBITDA |
10.30 | 9.18 | 12.70 | 10.94 | |
Debt/Assets |
70.54% | 69.25% | 71.52% | 74.81% | |
Debt/Equity |
(4.32) | (4.59) | (3.91) | (3.33) | |
Asset Turnover |
1.86 | 1.85 | 1.83 | 1.85 | |
Operating CF/Net income |
(1.25) | 1.84 | 1.15 | 3.21 | |
Capex/Depreciation |
(0.36) | (0.37) | (0.63) | (0.68) | |
Interest Coverage |
0.00 | 0.00 | 0.00 | 0.00 | |
Research and Development Expense of Revenue |
0.00% | 0.00% | 0.00% | 0.00% | |
Selling, General and Administrative Expense of Revenue |
68.00% | 67.81% | 69.75% | 67.81% | |
Intangible Assets out of Total Assets |
0.16 | 0.14 | 0.15 | 0.15 | |
Share Based Compensation of Revenue |
0.76% | 0.80% | 0.85% | 0.88% | |
Graham Net Nets |
(1.57) | (1.35) | (1.62) | (2.52) | |
Graham Number |
0.00 | 0.00 | 0.00 | 0.00 | |
Earnings Yield |
12.17% | 15.83% | 17.30% | 37.44% | |
Free Cash Flow Yield |
23.45% | 24.47% | 19.09% | 24.89% | |
Revenue per Share |
12.70 | 12.69 | 12.48 | 12.33 | |
Operating CF per Share |
0.31 | 1.10 | 0.96 | 1.34 | |
Capex per Share |
(0.11) | (0.10) | (0.18) | (0.20) | |
Free Cash Flow per Share |
0.21 | 0.99 | 0.78 | 1.14 | |
Cash per Share |
3.55 | 4.35 | 3.43 | 2.96 | |
Shareholders Equity per Share |
(4.47) | (4.18) | (4.96) | (5.87) | |
Interest Debt per Share |
0.00 | 0.00 | 0.00 | 0.00 | |
Book value per Share |
(4.47) | (4.18) | (4.96) | (5.87) | |
Free Cash Flow |
21.60 | 102.90 | 79.80 | 118.00 | |
Working Capital |
195.30 | 230.00 | 131.80 | 106.30 | |
Capital Expenditures |
(11.30) | (10.90) | (18.50) | (20.80) | |
Net Current Asset Value |
(2,155.80) | (2,057.30) | (2,150.60) | (2,197.00) | |
EV/EBIT |
6.13 | 6.18 | 6.16 | 5.30 | |
Capex to Sales |
0.01 | 0.01 | 0.01 | 0.02 | |
Net Profit Margin |
(1.98%) | 4.70% | 6.66% | 3.39% | |
Price to Operating Income |
2.79 | 3.08 | 2.75 | 1.79 | |
| Other line items | |||||
Average Receivables |
106.05 | 98.05 | 80.40 | 89.90 | |
Average Payables |
96.55 | 86.75 | 84.90 | 87.35 | |
Average Inventory |
510.40 | 491.30 | 493.55 | 513.90 | |
Average Assets |
2,796.90 | 2,779.75 | 2,757.00 | 2,675.35 | |
Average Common Equity |
(560.65) | (585.10) | (655.25) | (780.10) |
Columns are period end dates